The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.
Health
·
Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
CN
CitrixNews Staff
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Health
Right now, we could be living through a hantavirus disaster. The world avoided that, and this is why | Devi Sridhar
As the isolation period comes to an end for those caught up in the outbreak on a cruise ship, let’s celebrate a good new...
CitrixNews Staff
·
2 hours ago
Health
Why is it so hard to show yourself compassion?
Kimberley Wilson discusses compassion on Complex.
CitrixNews Staff
·
4 hours ago
Health
Familiar Touch review – Kathleen Chalfant is wonderful in subtle, sensual memory loss drama
Director Sarah Friedland brings impressive attention to detail to an audacious debut feature about a woman moved into a ...
CitrixNews Staff
·
6 hours ago
Health
The Pain of Caring for a Parent Who Abused You
The United States is reliant on unpaid family caregivers, and millions of adult children are caring for parents who didn...
CitrixNews Staff
·
7 hours ago